Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 651.00 | 850.50 | 0.7654 | 0.5840 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 828.00 | 850.50 | 0.9735 | 0.9538 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 625.00 | 384.25 | 880.00 | 850.50 | 1.0347 | 1.0604 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 384.25 | 577.00 | 850.50 | 0.6784 | 0.4257 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 695.00 | 850.50 | 0.8172 | 0.6770 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 625.00 | 384.25 | 729.00 | 850.50 | 0.8571 | 0.7483 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 625.00 | 384.25 | 477.00 | 850.50 | 0.5609 | 0.2076 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 794.00 | 850.50 | 0.9336 | 0.8836 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 625.00 | 384.25 | 1282.00 | 850.50 | 1.5073 | 1.8609 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 970.00 | 850.50 | 1.1405 | 1.2431 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 625.00 | 384.25 | 553.00 | 850.50 | 0.6502 | 0.3738 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 625.00 | 384.25 | 866.00 | 850.50 | 1.0182 | 1.0318 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 742.00 | 850.50 | 0.8724 | 0.7755 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 625.00 | 384.25 | 493.00 | 850.50 | 0.5797 | 0.2429 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 863.00 | 850.50 | 1.0147 | 1.0256 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 829.00 | 850.50 | 0.9747 | 0.9558 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 625.00 | 384.25 | 497.00 | 850.50 | 0.5844 | 0.2517 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 394.00 | 850.50 | 0.4633 | 0.0221 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 625.00 | 384.25 | 959.00 | 850.50 | 1.1276 | 1.2209 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 984.00 | 850.50 | 1.1570 | 1.2713 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 625.00 | 384.25 | 819.00 | 850.50 | 0.9630 | 0.9352 |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 625.00 | 384.25 | 840.00 | 850.50 | 0.9877 | 0.9784 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 810.00 | 850.50 | 0.9524 | 0.9167 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 716.00 | 850.50 | 0.8419 | 0.7211 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 693.00 | 850.50 | 0.8148 | 0.6728 |